Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-year, Open-lable, Multi-center Extension Trial of Entecavir Therapy for Patients Previously Treated in Dragon Study

NCT01829685 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT01829685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-year, Open-lable, Multi-center Extension Trial of Entecavir Therapy for Patients Previously Treated in Dragon Study
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2013
Completion date
Not reported
Enrollment
360 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, inadequate response, nucleos(t)ide analogues treatment